Remove 2027 Remove IT Remove Patients Remove Provider
article thumbnail

Governor’s 2025-26 May Revision Proposes Major Cuts to Healthcare and Undermines Medi-Cal Expansion Commitments

California Academy of Family Physicians (CAFP)

However, for individuals who do not qualify for federal Medicaid funding—such as most undocumented immigrants—the federal government does not provide matching funds, even when those individuals meet income eligibility requirements. The May revision proposes eliminating and suspending much of this funding.

article thumbnail

Insurers Promise to Speed Up Delays in Health Care Approvals

Physician's Weekly

Starting next year, if a patient switches insurance plans while getting treatment, the new plan must honor the old plan’s prior authorization for at least 90 days. Insurers must provide clearer explanations when care is denied and explain how patients can appeal. But experts say the changes may not go far enough.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MN Legislative Session 2025: Updates on Hearings and Bills

Minnesota Academy of Family Physicians

Last week, the Minnesota Academy of Family Physicians (MAFP) was actively engaged in multiple discussions on health care policy, including Medical Assistance rate reimbursement, coverage for the Psychiatric Collaborative Care Model and broader reforms to patient-centered care. Read a summary of HF 1005. Read a summary of HF 958.

article thumbnail

From Surgeries To Keeping Company: The Place Of Robots In Healthcare

The Medical Futurist

Robotic nurses dressing mannequins and bed-bathing patients Delicate movement, like gently handling an elderly patient is traditionally the most challenging task to robots, who are much faster developing in intellectual tasks than matching humans in fine-motor skills. By 2027, global surgical robotics sales are expected to reach $14.8

article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

FDA Law Blog

FDA recognizes the potential of RWE to support regulatory submissions of medical devices and to inform benefit-risk analysis of such products, while assuring patients have timely access to devices. Rather than looking at how RWD/RWE provide meaningful information on safety and effectiveness, reviewers often focus on perceived gaps.

Medical 111
article thumbnail

Proposed LDT Rule Raises Many Questions but Provides Few Answers

FDA Law Blog

The Proposed Rule states that Stage 4 and Stage 5 would not begin before October 1, 2027, and April 1, 2028, respectively, in order to enable laboratories to participate in negotiations preceding user fee reauthorization in 2027 (taking effect in FY2028, which begins on October 1, 2027).

article thumbnail

The FDA PDUFA VII Goals Letter (FY 2023-2027): A Review of Our Top 10 Commitments

FDA Law Blog

When FDA published the fiscal years (FY) 2023-2027 goals letter at the end of August, making known their commitments and planned initiatives for the coming years, we were both excited by many of the announcements, while recognizing the real success will come from how the Agency implements them.